Programmed Death Ligand-1 Blocker [EPC]

7939 reported adverse events

Drugs of this class: AVELUMAB DURVALUMAB

These side effects are most commonly reported by patients taking drugs of the Programmed Death Ligand-1 Blocker [EPC] class:

# Side effect Count
0 DEATH 814
1 RADIATION PNEUMONITIS 629
2 MALIGNANT NEOPLASM PROGRESSION 615
3 PNEUMONITIS 499
4 PYREXIA 321
5 DYSPNOEA 302
6 DIARRHOEA 258
7 PNEUMONIA 233
8 OFF LABEL USE 232
9 FATIGUE 227
See all common reactions for Programmed Death Ligand-1 Blocker [EPC]

Drugs of the Programmed Death Ligand-1 Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RADIATION PNEUMONITIS 629 0.4082
1 PULMONARY RADIATION INJURY 10 0.2326
2 TUMOUR HYPERPROGRESSION 20 0.2273
3 ENDOCRINE TOXICITY 5 0.1786
4 LUNG SQUAMOUS CELL CARCINOMA RECURRENT 2 0.1667
5 RADIATION INTERACTION 11 0.1486
6 NON-SMALL CELL LUNG CANCER STAGE III 4 0.1429
7 NON-SMALL CELL LUNG CANCER RECURRENT 15 0.1210
8 IMMUNE-MEDIATED LUNG DISEASE 37 0.1194
9 BILIARY TRACT INFECTION 44 0.1045
See all enriched reactions for Programmed Death Ligand-1 Blocker [EPC]